Focused Issue on Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy

Posted On 2019-07-09 03:28:10


This focused issue on “Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy” is edited by Dr. Jia Wei, The Comprehensive Cancer Center, Affiliated Drum Tower Hospital to Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, China.

Dr. Jia Wei is now working as a medical oncologist and Associated Professor in the Comprehensive Cancer Center, Affiliated Drum Tower Hospital to Medical School of Nanjing University. Dr. Wei is the vice director of cancer center and the Clinical Cancer Institute of Nanjing University. She is also doctoral supervisor of Nanjing University. She received more than one-year training in personalized medicine based on molecular biology under the supervision of Dr. Rafael Rosell from 2007. She is the inaugural STO-CSCO International Fellow and received trainings at Harvard’s Brigham & Women’s Hospital, Massachusetts General Hospital Cancer Center and Dana-Farber Cancer Institute, Mayo Clinic and the National Cancer Institute. Dr. Wei has experiences of translational researches in gastric cancer. She has authored or co-authored 64 scientific articles in peer-reviewed journals, as well as several book chapters and presentations.

Focused issue outline:

  1. Hypoxic stress-induced tumor microenvironment reprogramming
  2. Microenvironment acidity in cancer immunomodulation
  3. Immune escape of exosomal induction
  4. Cancer-associated fibroblasts as modulators in tumor microenvironment
  5. Immunotherapeutic targeting of tumor-associated macrophages
  6. Antitumor effect of targeting myeloid-derived suppressor cells
  7. Nature killer cells and combination immunotherapy
  8. Regulation of CD8+ T lymphocytes in tumor microenvironment
  9. Prospects of oncolytic virotherapy combined with immunotherapy
  10. Targeting CXCR4 to regulate tumor microenvironment
  11. Targeting CCL2/CCR2 chemokine axis in immunotherapy
  12. Overcoming resistance to checkpoint inhibitors in myeloid cells
  13. Irradiated tumor microenvironment and immunotherapy response
  14. Microenvironment early detection by exosomes
  15. Molecular imaging analysis of tumor microenvironment
  16. Biomarkers of the Tumor Microenvironment